Jain, A., Tan, A. C., Budiman, A., Tan, K. P., Jackwee, L., Yue, L. S., Hang, L. J., Jun, L. Y., Chia, T. W., Schultheis, K., Jiang, N., Nallani, M., Tan, D. S. (2026). Phase 1 dose escalation of ACM-CpG, a polymersome-delivered TLR9 agonist for advanced solid tumors after prior treatment with checkpoint inhibitor.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.19_suppl.tps91